Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
NASDAQ:LIVN

LivaNova - LIVN Stock Forecast, Price & News

$52.40
-1.27 (-2.37%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$51.91
$53.94
50-Day Range
$43.88
$53.72
52-Week Range
$41.82
$89.69
Volume
296,697 shs
Average Volume
510,541 shs
Market Capitalization
$2.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$83.00

LivaNova MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
58.4% Upside
$83.00 Price Target
Short Interest
Healthy
3.51% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.45mentions of LivaNova in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
42.20%
From $1.73 to $2.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

289th out of 1,040 stocks

Electromedical Equipment Industry

3rd out of 23 stocks

LIVN stock logo

About LivaNova (NASDAQ:LIVN) Stock

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Stock News Headlines

LivaNova Reports Third-Quarter 2022 Results
Breakeven Is Near for LivaNova PLC (NASDAQ:LIVN)
LivaNova Enters Oversold Territory (LIVN)
See More Headlines
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Company Calendar

Last Earnings
11/02/2022
Today
11/29/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/22/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LIVN
Employees
3,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$83.00
High Stock Price Forecast
$96.00
Low Stock Price Forecast
$63.00
Forecasted Upside/Downside
+58.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-135,820,000.00
Pretax Margin
-8.24%

Debt

Sales & Book Value

Annual Sales
$1.04 billion
Cash Flow
$3.51 per share
Book Value
$24.32 per share

Miscellaneous

Free Float
53,320,000
Market Cap
$2.80 billion
Optionable
Optionable
Beta
0.85

Key Executives

  • Mr. Damien  McDonaldMr. Damien McDonald (Age 57)
    CEO & Director
    Comp: $3.48M
  • Mr. Alex Shvartsburg (Age 51)
    Chief Financial Officer
    Comp: $888.04k
  • Ms. Trui Hebbelinck (Age 50)
    Chief HR Officer
    Comp: $945.32k
  • Ms. Keyna Pidcock Skeffington (Age 59)
    Sr. VP, Special Advisor & Exec. Officer
    Comp: $1.19M
  • Mr. Marco  DolciMr. Marco Dolci (Age 60)
    Pres of Cardiopulmonary Bus. Unit
    Comp: $1.29M
  • Lindsey Little
    Sr. Director of Investor Relations
  • Mr. Michael Hutchinson
    Sr. VP, Chief Legal Officer and Company Sec.
  • Deanna Wilke
    VP of Corp. Communications
  • Mr. Matthew Joseph Dodds III
    Sr. VP of Corp. Devel.
  • Dr. Bryan D. Olin Ph.D. (Age 55)
    Sr. VP & Head of Product Devel. - Neuromodulation













LIVN Stock - Frequently Asked Questions

Should I buy or sell LivaNova stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LIVN shares.
View LIVN analyst ratings
or view top-rated stocks.

What is LivaNova's stock price forecast for 2023?

4 Wall Street research analysts have issued twelve-month price targets for LivaNova's shares. Their LIVN share price forecasts range from $63.00 to $96.00. On average, they expect the company's share price to reach $83.00 in the next year. This suggests a possible upside of 58.4% from the stock's current price.
View analysts price targets for LIVN
or view top-rated stocks among Wall Street analysts.

How have LIVN shares performed in 2022?

LivaNova's stock was trading at $87.43 on January 1st, 2022. Since then, LIVN shares have decreased by 40.1% and is now trading at $52.40.
View the best growth stocks for 2022 here
.

When is LivaNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our LIVN earnings forecast
.

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) issued its quarterly earnings data on Wednesday, November, 2nd. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.01. The firm earned $252.60 million during the quarter, compared to the consensus estimate of $246.53 million. LivaNova had a positive trailing twelve-month return on equity of 9.28% and a negative net margin of 9.14%.

What guidance has LivaNova issued on next quarter's earnings?

LivaNova updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of $2.25-$2.45 for the period, compared to the consensus EPS estimate of $2.30. The company issued revenue guidance of $1.08 billion-$1.10 billion, compared to the consensus revenue estimate of $1.01 billion.

What is Damien McDonald's approval rating as LivaNova's CEO?

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.

What other stocks do shareholders of LivaNova own?
What is LivaNova's stock symbol?

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

Who are LivaNova's major shareholders?

LivaNova's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.99%), Primecap Management Co. CA (8.55%), State Street Corp (4.78%), Barrow Hanley Mewhinney & Strauss LLC (4.56%), Eminence Capital LP (3.90%) and Dimensional Fund Advisors LP (1.93%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends
.

How do I buy shares of LivaNova?

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LivaNova's stock price today?

One share of LIVN stock can currently be purchased for approximately $52.40.

How much money does LivaNova make?

LivaNova (NASDAQ:LIVN) has a market capitalization of $2.80 billion and generates $1.04 billion in revenue each year. The company earns $-135,820,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis.

How many employees does LivaNova have?

The company employs 3,000 workers across the globe.

How can I contact LivaNova?

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332.

This page (NASDAQ:LIVN) was last updated on 11/29/2022 by MarketBeat.com Staff